SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-20-000538
Filing Date
2020-02-14
Accepted
2020-02-14 15:09:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 11 TO THE SCHEDULE 13G sc13ga1107422ccx_02142020.htm SC 13G/A 266842
2 JOINT FILING AGREEMENT ex991to13ga1107422ccx_021420.htm EX-99.1 10359
  Complete submission text file 0000921895-20-000538.txt   278746
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Subject) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86723 | Film No.: 20618534
SIC: 2834 Pharmaceutical Preparations